Tag Archives: cardiac arrest

Introduction The Johnson and Johnson Inc. (formerly Abiomed Inc.) Impella left ventricular assist devices (LVADs) are catheter-based, intravascular, transaortic micro-axial flow pumps that supplement native ventricular function while providing ventricular offloading. There are a range of left ventricular Impella devices of increasing size from Impella 2.5, Impella Cardiac Power (CP), Impella 5.0 and Impella 5.5. The Impella 2.5 and CP are inserted via a percutaneous femoral access route, and provide up to 3.5 L/min blood flow, whereas the Impella 5.0 is deployed surgically via a branch graft to the subclavian artery and provides up to 5 L/m

ARBITER 6: niacin superior to ezetimibe for slowing atherosclerosis Use of extended-release niacin resulted in a significant benefit on atherosclerosis compared with ezetimibe in patients already taking statins in the ARBITER 6-HALTS trial. The trial, presented at the meeting by Dr Allen Taylor (Medstar Research Institute, Washington DC, US), compared two distinct lipid-modifying strategies in patients with known vascular disease already on statins who had LDL-cholesterol levels <100 mg/dL (2.56 mmol/L) and moderately low HDL-cholesterol levels (<50 mg/dL [1.28 mmol/L]). Among the 363 patients enrolled in the study, half were randomised